<DOC>
	<DOCNO>NCT00468104</DOCNO>
	<brief_summary>The purpose study document efficacy safety intrapleural instillation Activase v Placebo management complicate pleural effusion empyemas</brief_summary>
	<brief_title>Efficacy Safety Activase ( Ateplase ) v Placebo Complicated Pleural Effusions ( CPE ) /Empyemas</brief_title>
	<detailed_description>The current treatment available complicated pleural effusion ( CPE ) include chest tube placement drainage IV antibiotic . If fails CPE occur patient thoracotomy perform . Patients surgical candidate image guide catheter placement perform , sometimes multiple time . The American College Chest Physicians ( ACCP ) form CPE panel publish guideline treat CPE . Percutaneous image-guided drainage common approach CPE . The panel recognize cumulative data support use fibrinolytics , VATS , thoracotomy . The CPE panel acknowledge lack randomized clinical trial determine efficacy safety modality CPE strongly encourage research take place . Fibrinolytic therapy relatively noninvasive , easy use , relatively inexpensive . If successful , prevent sepsis septic shock , decrease hospital stay , morbidity mortality prevent surgical procedure . Multiple dos fibrinolytics use CPE evidence systemic anti-fibrinolytic activity . Complications medication also uncommon isolated instance report . The benefit successful pleural drainage use agent decrease morbidity , mortality , surgical procedure , hospital stay .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Empyema</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Diagnosed complicated pleural effusion Ability provide write informed consent comply study assessment full duration study . Age &gt; 18 year Exclusion Criteria Current use oral anticoagulant ( e.g. , warfarin sodium ) International Normalized Ratio ( INR ) &gt; 5 Activated partial thromboplastin time ( aPPT ) &gt; 80 , Platelet count &lt; 100,000/mm3 ; Severe uncontrolled hypertension Recognized hypersensitivity Activase ; component formulation ; Traumatic pleural effusion Pregnancy ( positive pregnancy test ) In another study condition Any condition investigator believe would pose significant hazard subject investigational therapy initiate Participation another simultaneous medical investigation Recent stroke Intracranial hemorrhage arteriovenous malformation aneurysm Intracranial neoplasm Acute myocardial infarction Acute pulmonary embolus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>parapneumonic pleural effusion</keyword>
	<keyword>empyema</keyword>
	<keyword>TPA ( Activase , Alteplase )</keyword>
</DOC>